This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Home
Products
Trurapi®▼ (insulin aspart 100 units/mL)
Trurapi Hero Pen

Trurapi®

insulin aspart 100 units/mL

The first rapid acting insulin biosimilar of NovoRapid® approved in the UK and EU.1

Profile

30% lower NHS list price vs. NovoRapid® pre-filled pens and cartridges and 15% lower NHS list price vs. NovoRapid® vials.2

1:1 initial unit dosing - available in the SoloStar pen, cartridges and vials1*

*When transferring from other insulin products, dose adjustment of Trurapi® or basal insulin may be needed. Insulin aspart has a faster onset and shorter duration of action than soluble human insulin. Close glucose monitoring during transfer and initial weeks is recommended.1

Similar PK/PD profile (T1DM), efficacy, safety and tolerability (T1DM and T2DM).3-4

1/3

30% lower NHS list price vs. NovoRapid® pre-filled pens and cartridges and 15% lower NHS list price vs. NovoRapid® vials.2

1:1 initial unit dosing - available in the SoloStar pen, cartridges and vials1*

*When transferring from other insulin products, dose adjustment of Trurapi® or basal insulin may be needed. Insulin aspart has a faster onset and shorter duration of action than soluble human insulin. Close glucose monitoring during transfer and initial weeks is recommended.1

Similar PK/PD profile (T1DM), efficacy, safety and tolerability (T1DM and T2DM).3-4

Get in touch with the Diabetes Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023

MAT-XU-2205461 (v11.0)  Date of Preparation: March 2025